Please login to the form below
Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?
A rapid round-up of pharma, biotech and healthcare news
Daily Brief
A rapid round-up of the top pharma, biotech and healthcare news
Daily Brief: Deal done, Takeda to cut $1.4bn, Brexit latest, Valeant rebrands
A rapid round-up of the top pharma, biotech and healthcare news
Daily Brief: Takeda seals $62bn Shire deal, Autolus IPO, Gottlieb warning
A rapid round-up of the top pharma, biotech and healthcare news
Morning brief: New biotech launched, Merck and Moderna expand collaboration and more
A rapid round up of pharma, biotech and healthcare news
Esperion craters as deaths mar atherosclerosis drug study
But the company insists its atherosclerosis candidate didn’t cause the deaths
Regeneron’s Dupixent and Praluent falls short
But CEO Len Schleifer says there’s time to fix that
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more
A rapid round-up of pharma, biotech and healthcare news
J&J pays $140m upfront for cancer-busting virus firm BeneVir
The total value of the deal could go above $1bn if the biotech’s candidates perform well
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Nokia’s digital health unit returns to its rootsÉric Carreel plans to reacquire the business
-
Pfizer’s flat sales focus investor attention on M&ABut CEO Ian Reed insists that there is no need for a large-scale acquisition
-
Morning brief: CAR-T competition hots up, Keytruda sales soar and moreA rapid round-up of pharma, biotech and healthcare news
-
Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and moreA rapid round up of pharma, biotech and healthcare news
-
Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and moreA rapid run-down of news in pharma, biotech and healthcare
-
Sandoz targets digital therapeuticsPartners with Pear Therapeutics to launch FDA-approved apps
-
Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more -
Dr Martin Rothman joins Sofinnova PartnersHe becomes the firm’s venture partner
-
Gamida Cell strengthens leadership teamAppoints Josh Hamermesh and Paul Nee
-
Pharnext appoints COOAmit Kohli joins the biopharma from Eurofins
-
Neurimmune appoints chief business officer
Fabian Buller will further drive the biopharma’s growth strategy
-
ProPharma selects new CEO and president
Dawn Sherman takes up the roles effective 14 May
Latest sales appointments
Featured jobs
- Assistant Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
-
Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Director – Healthcare PR
-
Salary TBC
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
-
Associate Director, Healthcare PR
-
£60, 000 – £67, 000+ benefits
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Sales & Marketing Manager - New Launch - Mental Health - S E...
-
Highly Competitive Basic, Bonus &Benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
Subscribe to our email news alerts
- Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer
- Immuno-oncology at ASCO: survival data, combinations and new indications
- Novartis, Amgen set low price for first CGRP migraine drug
- Moving annual total (MAT)
- Key success factor (KSF)
- Janssen named ‘Pharma Company of the Year’ at business intelligence awards
- We can be heroes
- What does ‘digital’ look like for global pharma Learning & Development?
- FDA starts review of Sanofi’s oral type 1 diabetes drug
- Is the pharma business model ready for precision medicine?
- Porterhouse Medical announces another well-deserved promotion within the group
- FDA clears Dova drug for liver-related low blood platelets
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- Is the pharma business model ready for precision medicine?
- Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
- The NHS and ABPI at 70: inching closer to the triple win
- The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
- What pharma marketers can learn from behavioural science
- Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
Quick links
Infographics
